Global Mycoplasma Testing Market Threats, Analysis, Key Players, Growth, and Forecast 2026

North America continues to dominate in global mycoplasma testing market, followed by Europe.

Mycoplasma is a prokaryotic organism and a frequent occult contaminant of cell cultures. Without a cell wall around the cell membrane, they are unaffected by many common antibiotics such as penicillin or other beta-lactam antibiotics that target cell wall synthesis. This species of organism is the smallest bacterial cells yet discovered and can survive without oxygen, and come in various shapes. Mycoplasma contamination is relatively common and can persist for a long time while remaining undetected. Mycoplasma contamination also adversely affects the research work of scientists in laboratories. Since this organism can modify many aspects of cell physiology, experiments that are conducted with previously contaminated cells become useless. Because of their small size, mycoplasmas can pass through filters used to prevent bacterial and fungal contamination and potentially spread to all cultures in a laboratory. Mycoplasma contamination can also occur through workers who are infected with M. orale or M. fermentans. Thus, it is essential that all new cell cultures entering a laboratory and all cell banks are tested for presence of mycoplasma in order to generate robust data in the field of biomedical research.

Mycoplasma testing is carried out in the research and production of all biopharmaceutical products. Growth in the pharmaceutical and biotechnology sector across the globe serves as a direct driver for associated markets such as mycoplasma testing. Moreover, increasing healthcare spending in developing countries and increasing pharmaceutical outsourcing is creating opportunities for growth of the mycoplasma testing market. However, some factors restraining market growth include stringent government regulations and high cost associated with mycoplasma testing.

The global market is segmented on the basis of product, technique, application, end user, and region. By product, the market is segmented into kits & reagent, PCR assay, nucleic acid detection, elimination kits & reagent, stains, standards & controls, services, and instruments. On the basis of technique, the market is segmented into PCR, ELISA, direct assays, indirect assays, DNA staining, microbial culture techniques, and enzymatic methods. On the basis of application, the mycoplasma testing market is segmented into cell line testing, virus testing, end-of-production cell testing, and other applications. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, academic research institutes, contract research organizations (CROs), cell banks, and other end users. On the basis of region, the market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

The global mycoplasma testing market is dominated by North America, which is expected to continue its dominance over the forecast period, followed by Europe. However, Asia Pacific is expected to witness highest revenue CAGR expansion, with major revenue contribution coming from markets in China, Japan, and India due to growing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.

Mycoplasma Testing Market, by Product

 	
Kits & Reagents
 	
PCR Assay
 	
Nucleic Acid Detection
 	
Elimination Kits & Reagents
 	
Stains
 	
Standards & Controls
 	
Other Kits & Reagents
 	
Services
 	
Instruments

Mycoplasma Testing Market, by Technique

 	
PCR
 	
ELISA
 	
Direct Assay
 	
Indirect Assay
 	
DNA Staining
 	
Microbial Culture Techniques
 	
Enzymatic Methods

Mycoplasma Testing Market, by Application

 	
Cell Line Testing
 	
Virus Testing
 	
End of Production Cells Testing
 	
Other Applications

Mycoplasma Testing Market, by End Users

 	
Pharmaceutical and Biotechnology Companies
 	
Academic Research Institutes
 	
Contract Research Organizations (CROs)
 	
Cell Banks
 	
Other End Users

Mycoplasma Testing Market, by Region

 	
Europe
 	
North America
 	
Asia Pacific
 	
Latin America
 	
Middle East & Africa

Key Players:

 	
Thermo Fisher Scientific Inc.
 	
Charles River Laboratories International Inc.
 	
Lonza Group Ltd.
 	
Merck KGaA
 	
Roche Diagnostics
 	
SGS S.A.
 	
American Type Culture Collection
 	
Bionique Testing Laboratories Inc.
 	
InvivoGen
 	
PromoCell GmbH
 	
Biological Industries Israel Beit Haemek Ltd.
 	
WuXi AppTec
 	
Norgen Biotek Corp.
 	
Agilent Technologies
 	
Biotools
 	
B & M Labs
 	
Eurofins Scientific
 	
Gibraltar Laboratories
 	
GeneCopoeia
 	
 GenBio
 	
Hylabs
 	
Minerva Biolabs GmbH
 	
Meridian Bioscience Inc.
 	
Sartorius AG
 	
Savyon Diagnostics
 	
ScienCell Research Laboratories Inc.

Report Structure:

In the first section of the report we offer a table of content, followed by a list of figures. The next section offers a definition and brief explanation of the various products and segmentation of the target market, along with a list of acronyms and sources used to gather and analyze data and information.

The third section of the report entails a brief list of drivers, restraints, opportunities, and threats (DROTs) in the target market. The report also offers insights on various trends in regions, countries, and markets as per segmentation, as well as insights and crucial information obtained from various sources including primary and secondary, annual reports, the Internet and others.

The final section comprises detailed profiles of key players in the target market and a SWOT analysis of each company, apart from strategies, acquisitions and mergers.

Objective of Report:

Sections of the report are created and designed specifically to offer readers a clear, clean, and insights into historical, estimated, and revenue (US$ Mn/Bn) estimation and projection, Compounded Annual Growth Rate (CAGR %), and volume in measure as applicable to the target product/market. We offer illustrations, charts, tables, and figures to support our findings and analysis, in addition to key finding for markets in regions and countries. This report is valuable asset for the existing players, new entrants and the future investors.

Who we are and what we do:

Market.biz is a pioneering company in the fields of market research and analytical reporting. Our services enable clients to enhance business efficiency and focus on other core aspects of operations, while we take care of market research and reporting needs. Market.biz conducts and executes detailed and in-depth research and analysis across all relevant domains and offers accurate and insightful estimations and forecasts to enable clients to take well-informed and crucial decisions in their respective industries, sectors, or companies.

Market.biz has access to the world’s most comprehensive and up-to-date databases in any business sector, as we understand the specific and varying needs of our clients. We offer updated reports to keep up with the changing scenarios in global markets and strive to ensure that only the utmost quality is established and maintained in every single report we produce. Our reports are conveniently designed and structured and are visually-pleasing. We provide a detailed analysis outlook of competitive markets and identify and study new and emerging trends and other crucial aspects and factors impacting or driving market growth. We also offer insights regarding new and emerging opportunities in the market and present the information in a comprehensive report focused on your respective market or sector.